CLEVELAND—Lubrizol Corp.'s LifeSciences business said it will spend $10 million to expand capacity at its Vesta silicone contract manufacturing site in Franklin, Wis.
The project adds 71,000 square feet to the existing 126,000-sq.-ft. operation. Lubrizol said the expansion "supports LifeSciences' long-term growth strategy to provide high-quality manufacturing for silicone implants and finished medical devices."
Vesta doubled the footprint at the site in 2010, four years before Cleveland-based Lubrizol acquired the silicone goods producer.
"When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process," states Uwe Winzen, general manager, Lubrizol LifeSciences, said in a statement. "With a long history of polymer expertise combined with recent investments, Lubrizol LifeSciences is positioned to offer full-service development for the next generation of medical devices, as well as long-term implantable and drug-eluting device innovations."
The expansion features product development, cellular manufacturing and high-efficiency production lines, along with separate Class 7 and 8 clean rooms for the production of implants and drug-eluting devices, according to Lubrizol.
Vesta General Manager Mark Stuart said the space covers short-term needs but also provides room for future growth.
"Companies looking for a world-class, efficient contract manufacturing partner can choose us knowing that we are a sustainable partner for their long term growth," he said.